scholarly article | Q13442814 |
P50 | author | Luca Cantarini | Q30505846 |
Matteo Piga | Q37829183 | ||
Giuseppe Lopalco | Q38544880 | ||
Florenzo Iannone | Q38544900 | ||
Elena Bartoloni | Q54060870 | ||
Gianfranco Vitiello | Q55089386 | ||
Paolo Sfriso | Q58328239 | ||
Lorenzo Dagna | Q60309835 | ||
Giacomo Emmi | Q61086244 | ||
Serena Colafrancesco | Q61146517 | ||
Angela Tincani | Q73304219 | ||
Giovanni Lapadula | Q38544910 | ||
Maurizio Rossini | Q41067734 | ||
Giulio Cavalli | Q42209239 | ||
Paola Cipriani | Q42416415 | ||
Roberto Giacomelli | Q42416418 | ||
Raffaele Manna | Q44815277 | ||
Carlomaurizio Montecucco | Q47265945 | ||
Elisa Gremese | Q50166371 | ||
Roberto Gerli | Q73737873 | ||
G Valesini | Q85230265 | ||
Roberta Priori | Q87167983 | ||
Donato Rigante | Q87442620 | ||
Elena C Cavallaro | Q87888765 | ||
Piero Ruscitti | Q88511212 | ||
Daniele Cammelli | Q89890433 | ||
Marta Mosca | Q90560735 | ||
Ilaria Piazza | Q91329276 | ||
Paola Galozzi | Q91923448 | ||
Jurgen Sota | Q92131554 | ||
Rosaria Talarico | Q94547617 | ||
Carla Gaggiano | Q98649610 | ||
Maria Grazia Massaro | Q99400905 | ||
Elena Silvestri | Q113819135 | ||
Salvatore De Vita | Q114291040 | ||
Elena Baldissera | Q114314178 | ||
Giovanni Canestrari | Q114314179 | ||
Ginevra De Marchi | Q114314182 | ||
Micol Frassi | Q114314183 | ||
Alessandro Mathieu | Q114314184 | ||
Irene Pontikaki | Q114314185 | ||
Micol Romano | Q114314186 | ||
Chiara Stagnaro | Q114314187 | ||
Ombretta Viapiana | Q114314188 | ||
Lorenza Maria Argolini | Q114417395 | ||
P2093 | author name string | Silvia Rossi | |
Gianfranco Ferraccioli | |||
Antonio Vitale | |||
P2860 | cites work | Life-threatening complications of adult-onset Still's disease | Q33412732 |
"Adolescent-onset Still's disease": characteristics and outcome in comparison with adult-onset Still's disease | Q34137374 | ||
Adult-onset Still's disease. Clinical course and outcome | Q34191960 | ||
Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study | Q34292030 | ||
Preliminary criteria for classification of adult Still's disease | Q34405573 | ||
The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis | Q34774277 | ||
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey | Q35122583 | ||
Is Still's Disease an Autoinflammatory Syndrome? | Q35955190 | ||
Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent | Q36183846 | ||
Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review. | Q36195807 | ||
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers | Q36208563 | ||
Adult Still's disease: manifestations, disease course, and outcome in 62 patients | Q37670649 | ||
Cutaneous manifestations associated with adult-onset Still's disease: important diagnostic values | Q37971317 | ||
Systemic juvenile idiopathic arthritis | Q38033873 | ||
Cutaneous manifestations of adult-onset Still's disease: a case report and review of literature | Q38204937 | ||
Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. | Q51740150 | ||
Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease. | Q52884955 | ||
Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. | Q54695048 | ||
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes | Q58326254 | ||
Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience | Q61911597 | ||
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study | Q38703626 | ||
A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner | Q38773387 | ||
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease. | Q39673488 | ||
Persistent pruritic papules and plaques associated with adult-onset Still's disease: report of six cases | Q40214423 | ||
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series | Q40335671 | ||
Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases | Q40356429 | ||
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France | Q40436579 | ||
Efficacy and safety of biological agents in adult-onset Still's disease. | Q41472240 | ||
A case of refractory adult-onset Still's disease treated with anakinra | Q42939560 | ||
Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still's disease | Q43025256 | ||
Adult onset Still's disease with persistent skin lesions complicated by secondary hemophagocytic lymphohistiocytosis | Q43563929 | ||
Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy | Q44201170 | ||
Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease | Q44602919 | ||
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register | Q47580938 | ||
Proposal for a new set of classification criteria for adult-onset still disease | Q78069999 | ||
Is Still's disease an autoinflammatory syndrome? | Q82976137 | ||
Evanescent and persistent pruritic eruptions of adult-onset still disease: a clinical and pathologic study of 36 patients | Q84420763 | ||
Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis | Q84973391 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anakinra | Q415411 |
Still's disease | Q3281303 | ||
P304 | page(s) | 296 | |
P577 | publication date | 2019-04-02 | |
P1433 | published in | Frontiers in Pharmacology | Q2681208 |
P1476 | title | Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response | |
P478 | volume | 10 |
Q90049900 | Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease |
Q90182004 | Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes |
Q89665968 | Editorial: New Therapies in the Field of Rheumatology |
Q97653199 | Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations |
Search more.